Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder ; volume:19 ; number:1 ; day:18 ; month:6 ; year:2024 ; pages:1-6 ; date:12.2024
Addiction science & clinical practice ; 19, Heft 1 (18.6.2024), 1-6, 12.2024
- Urheber
-
Azar, Pouya
Schneiderman, Hannah
Barron, Henry
Wong, James S. H.
Meyer, Maximilian
Newman-Azar, Dayyon
Narimani, Matin
Ignaszewski, Martha J.
Mathew, Nickie
Mullen, Rodney
Krausz, Reinhard M.
Maharaj, Anil R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-024-00479-1
- URN
-
urn:nbn:de:101:1-2409110921305.350670777334
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Azar, Pouya
- Schneiderman, Hannah
- Barron, Henry
- Wong, James S. H.
- Meyer, Maximilian
- Newman-Azar, Dayyon
- Narimani, Matin
- Ignaszewski, Martha J.
- Mathew, Nickie
- Mullen, Rodney
- Krausz, Reinhard M.
- Maharaj, Anil R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Single high-dose buprenorphine for opioid craving during withdrawal
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Single high-dose buprenorphine for opioid craving during withdrawal
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Transdermal buprenorphine in cancer pain and palliative care
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Single high-dose buprenorphine for opioid craving during withdrawal
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder